Form 4: Haemonetics Corp Executive Maryanne Maunsell Farris Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Maryanne Maunsell Farris, VP and Chief Accounting Officer of Haemonetics Corp, reports a transaction involving the withholding of shares for tax obligations related to vesting restricted stock units.
Summary
- On May 15, 2024, Maryanne Maunsell Farris, VP and Chief Accounting Officer of Haemonetics Corp, reported a transaction.
- 73 shares of common stock were disposed of to cover tax obligations related to the vesting of restricted stock units (RSUs) at a price of $96.49 per share.
- Following the transaction, Ms. Farris beneficially owns 557 shares of Haemonetics Corp, which includes unvested RSUs.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing regarding stock transactions, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine tax-related stock disposal.
Key Dates
| Date | Description |
|---|---|
| 05/15/2024 | Date of transaction: shares withheld for tax obligations. |
| 05/17/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.